Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Gupta AshimCOO & CFO | Grant or award | A | — 306.7K sh | Apr 1, 2026 |
| 16 | Reynolds Howard IDirector | Grant or award | A | $50K 3,189 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 16 | Hutchings JeanaDirector | Grant or award | A | $50K 3,179 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 16 | Mckinney Suzet MDirector | Grant or award | A | $56K 404 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 16 | Weichselbaum AlanDirector | Grant or award | A | $50K 3,179 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 16 | Mat IshbiaDirector, President and CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $3.63M 1.00M sh | Apr 1, 2026 traded Apr 1, 2026 |
| 16 | Brown Marianne CatherineDirector | Grant or award | A | $91K 377 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 16 | Ramani HiteshChief Accounting Officer | Tax withholding | F | $200K 18.0K sh | Apr 1, 2026 traded Apr 1, 2026 |
| 15 | Gupta AshimCOO & CFO | Tax withholding | F | $339K 30.5K sh | Apr 1, 2026 traded Apr 1, 2026 |
| 15 | Gallagher Thomas P.Director, Chairman & CEO | Tax withholding | F | $783K 20.9K sh | Apr 1, 2026 traded Mar 30, 2026 |
| 15 | Espinosa Paz JosefinaDirector | Grant or award | A | — 1,089 sh | Apr 1, 2026 traded Mar 25, 2026 |
| 15 | Stines Andrew GSee Remarks | Grant or award | A | $300K 19.1K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 14 | Ugwumba Chidozie10% Owner | Open-market sale | SELL | $21K 4,278 sh | Apr 1, 2026 traded Apr 1, 2026 |
| 14 | Longhito ChristopherFMR SVP & CSCO | Option exercise | M | $85K 2,927 sh | Apr 1, 2026 traded Mar 27, 2026 |
| 13 | Hyun RandyDirector | Grant or award | A | $25K 2,294 sh | Apr 1, 2026 traded Apr 1, 2026 |
| 13 | Ballew NealCHIEF ACCOUNTING OFFICER | Option exercise | M | — 14.9K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Savitz RyanEVP, CFO & CBO | Option exercise · 10b5-1 plan | M | $715K 40.0K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Bang Jimmy MChief Lending Officer | Option exercise | M | — 1,020 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Gallo Ann CDirector | Grant or award | A | — 323 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Segedi Bryan KDirector | Grant or award | A | $44K 878 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | McClintock WilliamDirector | Grant or award | A | — 52 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Ballew NealCHIEF ACCOUNTING OFFICER | Option exercise | M | — 5,620 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Mettler JodyChief Operating Officer | Grant or award | A | — 8,000 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 13 | Greenwood Matthew AChief Commercial Officer | Disposition to issuer | D | $47K 7,564 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Pomerantz Jennifer S.Director | Grant or award | A | — 2,351 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Bang Jimmy MChief Lending Officer | Tax withholding | F | $4,336 326 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Rogers Matthew CDirector | Grant or award | A | $44K 878 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Lillie Charisse RDirector | Grant or award | A | $44K 878 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Sumner Michael JohnChief Medical Officer | Option exercise | M | — 4,292 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Gourmand Matthew PaulPresident | Option exercise | M | — 14.9K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Gourmand Matthew PaulPresident | Option exercise | M | — 14.9K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Ballew NealCHIEF ACCOUNTING OFFICER | Option exercise | M | — 14.9K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Potts Charles EdwardDirector | Grant or award | A | — 1,186 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 12 | Cree BrianPresident & Interim CEO | Grant or award | A | — 54.2K sh | Apr 1, 2026 traded Mar 26, 2026 |
| 12 | Brown ShellyEVP, Chief Strategy Officer | Option exercise | M | $100K 3,878 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 12 | Giordano James NDirector | Grant or award | A | $50K 3,179 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 12 | McAleenan KevinDirector, Chief Executive Officer | Tax withholding | F | $68K 22.4K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 12 | McAleenan KevinDirector, Chief Executive Officer | Tax withholding | F | $139K 39.4K sh | Apr 1, 2026 traded Apr 1, 2026 |
| 12 | Brown ShellyEVP, Chief Strategy Officer | Option exercise | M | $100K 5,040 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 12 | Brown ShellyEVP, Chief Strategy Officer | Option exercise | M | $100K 6,195 sh | Apr 1, 2026 traded Mar 30, 2026 |